Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Efficacy and Tolerability of Bupropion Extended Release (Wellbutrin XL) for the Treatment of Major Depressive Disorder in Women With Breast Cancer

NCT00234195 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.

NCT NCT00234195
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00234195 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Efficacy and Tolerability of Bupropion Extended Release (Wellbutrin XL) for the Treatment of Major Depressive Disorder in Women With Breast Cancer
Lead sponsor
Thomas Jefferson University
Phase
Phase 4
Overall status
Completed
Start date
September 30, 2005
Completion date
January 31, 2007
Enrollment
25
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, major depressive disorder